Beam Therapeutics, Inc. (BEAM)
27.51
+0.11
(+0.40%)
USD |
NASDAQ |
Dec 11, 16:00
27.51
0.00 (0.00%)
After-Hours: 07:40
Beam Therapeutics Research and Development Expense (Quarterly): 109.77M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 12.30M |
| Intellia Therapeutics, Inc. | 92.33M |
| Regeneron Pharmaceuticals, Inc. | 1.338B |
| Twist Bioscience Corp. | 17.01M |
| Amicus Therapeutics, Inc. | 23.42M |